Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising virus-specific and anti-myeloma T-cell responses

Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising virus-specific and anti-myeloma T-cell responses

Not available.

Bibliografiske detaljer
Main Authors: Mehmet H. Kocoglu, Paul G. Richardson, Clifton C. Mo, Aaron P. Rapoport, Djordje Atanackovic
Format: Article
Sprog:English
Udgivet: Ferrata Storti Foundation 2024-02-01
Serier:Haematologica
Online adgang:https://haematologica.org/article/view/11471

Internet

https://haematologica.org/article/view/11471

Lignende værker